Cytokinetics (CYTK)

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

{% set status = marketHours.currentMarketStatus if marketHours.currentMarketStatus == "pre-market" or marketHours.currentMarketStatus == "after-hours" %}{% set hasHighAndLow = tickerData.data[dynamicVariables.equity upper].high and tickerData.data[dynamicVariables.equity upper].low %}{% if resolvedDynamicVariables[dynamicVariables.equity].subclass == "stock" %} () 股票 今日價格為 ，自市場 {% if status %} 上次收盤 {% else %} 開盤以來錄得 變動。該公司的市值為 ，日交易量為 股。{% if hasHighAndLow %}對於關注價格走勢的投資者而言， 股票今日的波動區間介於 和 之間。{% endif %} 上一個收盤價為 。{% else %} () ETF 今日價格為 。  ETF 當前 {% if resolvedDynamicVariables[dynamicVariables.equity].market_cap %} 市值為 ，{% endif %} 日交易量為 股。

{% if hasHighAndLow %}對於分析 ETF 表現的投資者而言， 當天的波動區間在 和 之間，前一交易日收盤價為 。透過這些資料可以深入了解近期的價格波動和流動性。{% endif %}

{% endif %}

是否準備好開始交易？請按照以下步驟操作，或閱讀我們的指南 如何在 Kraken 上購買 Cytokinetics 股票，起始金額為 $10。